Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print June 15, 2007
DOI: 10.2337/db06-1596

This Article
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db06-1596v1
56/9/2201    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dong, F.
Right arrow Articles by Ren, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dong, F.
Right arrow Articles by Ren, J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Metallothionein Prevents High Fat Diet-Induced Cardiac Contractile Dysfunction: Role of Peroxisome Proliferator-Activated Receptor {gamma} Coactivator-1{alpha} and Mitochondrial Biogenesis

Feng Dong1, Qun Li1, Nair Sreejayan1, Jennifer M. Nunn1, and Jun Ren1

1Center for Cardiovascular Research and Alternative Medicine, University of Wyoming, Laramie, WY 82071

Correspondence: jren{at}uwyo.edu

Key Words: antioxidant • high fat • myocardial function • mitochondrial biogenesis • PGC-1{alpha}

Obesity is associated with oxidative stress, mitochondrial and myocardial dysfunction although interaction among which remains elusive. This study was designed to evaluate the impact of the free radical scavenger metallothionein on high fat diet-induced myocardial, intracellular Ca2+ and mitochondrial dysfunction. FVB and metallothionein transgenic mice were fed a high or low fat diet for 5 months to induce obesity. Echocardiography revealed decreased fractional shortening, increased end systolic diameter and cardiac hypertrophy in high fat-fed FVB mice. Cardiomyocytes from high fat-fed FVB mice displayed enhanced ROS production, contractile and intracellular Ca2+ defects including depressed peak shortening and maximal velocity of shortening/relengthening, prolonged duration of relengthening, reduced intracellular Ca2+ rise and Ca2+ clearance. Transmission microscopy noted overt mitochondrial damage with reduced mitochondrial density. Western blot analysis revealed enhanced phosphorylation of nuclear factor Foxo3a without changes in Foxo3a, Foxo1a, pFoxo1a, silent information regulator (Sirt), Akt and pAkt in high fat diet-fed FVB hearts. The PPAR{gamma} coactivator 1{alpha} (PGC-1{alpha}), a key regulator of mitochondrial biogenesis, was significantly depressed by high fat diet feeding and in vitro palmitic acid treatment. RT-PCR further depicted reduced levels of the PGC-1{alpha} downstream nuclear respiratory factors 1,2, mitochondrial transcription factor A and mitochondrial DNA copy number in high fat-fed FVB hearts. Intriguingly, the high fat diet-induced alterations in ROS, myocardial contractile, mitochondrial and cell signaling were negated by metallothionein with the exception of pFoxo3a. These data suggest that metallothionein may protect against high fat diet-induced cardiac dysfunction possibly associated with upregulation of PGC-1 {alpha} and preservation of mitochondrial biogenesis.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.